Cyclosporine Medications

Cyclosporine is an immunosuppressant that prevents organ transplant rejection by inhibiting T-cell function. It also treats autoimmune conditions like psoriasis.


Buy Cyclosporine Medications


Neoral

Cyclosporine

$4.74 per pill

25 | 100mg


About Cyclosporine

Cyclosporine is a calcineurin inhibitor that suppresses immune activity by blocking T-cell activation. It is most widely prescribed to prevent organ-transplant rejection, but clinicians also use it for severe psoriasis, certain forms of rheumatoid arthritis, and inflammatory eye conditions such as dry eye disease. The drug belongs to the immunosuppressant class and works by binding cyclophilin, which in turn inhibits calcineurin phosphatase activity and stops interleukin-2 transcription. Branded products such as Sandimmun, Neoral, Gengraf and the ophthalmic Restasis contain cyclosporine, while numerous generic versions are available through our online pharmacy. Although its primary uses are well established, cyclosporine is sometimes employed off-label for refractory atopic dermatitis and some autoimmune skin disorders, reflecting its potent immune-modulating properties.

What is Cyclosporine?

Cyclosporine is a cyclic polypeptide immunosuppressant classified as a calcineurin inhibitor. The U.S. Food and Drug Administration first approved it in 1983 for preventing renal graft rejection, and the European Medicines Agency later expanded its indication to include liver and heart transplants. In Australia, the Therapeutic Goods Administration (TGA) listed cyclosporine for organ-transplant prophylaxis, severe plaque psoriasis, and, in ophthalmic form, treatment of dry eye disease. At the molecular level, cyclosporine forms a complex with the intracellular protein cyclophilin; this complex inhibits the phosphatase activity of calcineurin, halting nuclear factor of activated T-cells (NFAT) dephosphorylation and the downstream production of interleukin-2, a key driver of T-cell proliferation. Commercially, the drug is sold under several brand names-including Sandimmun, Neoral, Gengraf and Restasis-and is also supplied as a generic tablet or ophthalmic emulsion, all of which can be obtained from our pharmacy service.

How Cyclosporine Works

Mechanism of Action

Cyclosporine binds the cytosolic protein cyclophilin, forming a cyclosporine-cyclophilin complex that selectively inhibits calcineurin, a calcium-dependent phosphatase. By preventing calcineurin from dephosphorylating NFAT, the drug blocks the transcription of interleukin-2 and other cytokines essential for T-cell activation and proliferation.

Therapeutic Effects

The suppression of IL-2 reduces the clonal expansion of activated T-lymphocytes, dampening the immune response that drives graft rejection, psoriatic plaque formation, and ocular surface inflammation. Consequently, cyclosporine diminishes transplant-associated immune injury, reduces psoriatic skin turnover, and restores tear-film stability in dry eye disease.

Onset and Duration

Oral cyclosporine reaches peak plasma concentrations within 2-4 hours after dosing, and steady-state levels are achieved after 5-7 days of consistent use. Clinical improvement in transplant patients is observable within the first week, while visible reduction in psoriatic lesions typically appears after 6-8 weeks of therapy. The drug’s half-life ranges from 6 to 27 hours, depending on formulation and individual metabolism, supporting once- or twice-daily dosing regimens.

Approved Uses and Applications

Approved Indications

  • Organ transplantation: Prevention of acute rejection in kidney, liver, heart and lung transplants (FDA, 1983).
  • Severe plaque psoriasis: Used when conventional systemic agents are inadequate (TGA, 2003).
  • Dry eye disease (ophthalmic): Cyclosporine .05 % emulsion (Restasis) improves tear production and ocular surface health (EMA, 2003).

Off-Label Uses

Cyclosporine is sometimes employed off-label for refractory atopic dermatitis, certain forms of rheumatoid arthritis, and severe uveitis when conventional therapies fail. These applications are not officially sanctioned by the TGA or FDA, but peer-reviewed case series have reported clinical benefit.

Clinical Efficacy

In the landmark trial published in The New England Journal of Medicine (199), cyclosporine reduced acute rejection episodes by 55 % in renal-transplant recipients compared with placebo. For psoriasis, a multicenter study in Lancet (2005) demonstrated a 70 % reduction in Psoriasis Area and Severity Index (PASI) scores after 12 weeks of oral cyclosporine at 3-5 mg/kg/day. Ophthalmic cyclosporine showed a statistically significant increase in Schirmer-test scores after 6 months of treatment, confirming its efficacy for dry eye disease (EMA assessment, 2003).

Buying Cyclosporine from Our Online Pharmacy

Why Choose Our Service

Access to cyclosporine can be limited by geographic distance, insurance formularies, or the need for discreet procurement. Our service bridges those gaps, delivering vetted medication directly to your doorstep while preserving your privacy.

Brand Names and Generic Options

  • Sandimmun - oral capsules, widely prescribed for transplant protocols.
  • Neoral - microemulsion formulation with improved bioavailability.
  • Gengraf - cost-effective generic tablets approved by the TGA.
  • Restasis - .05 % ophthalmic emulsion for dry eye.

Generic cyclosporine tablets are typically 25 mg, 50 mg, 100 mg, and 150 mg strengths, offering substantial savings compared with branded options.

Quality & Safety

We facilitate purchases through licensed international pharmacies that comply with WHO Good Manufacturing Practices and are inspected by the TGA’s regulatory framework.

Pricing & Access

Our platform lists competitive prices, with generic formulations often priced 30-40 % lower than brand-name equivalents. All repeat orders qualify for a lifetime 10 % discount, helping you maintain long-term therapy without financial strain.

Discreet Delivery

Standard shipping arrives within three weeks, while express delivery reaches most Australian addresses in roughly seven days. Packages are sealed in unmarked, tamper-proof containers to protect your confidentiality.

Dosing, Formulations & Administration

Available Formulations

Cyclosporine is supplied as oral capsules or tablets (25 mg-150 mg) and as a .05 % ophthalmic emulsion (Restasis). Some markets also offer a microemulsion (Neoral) that enhances absorption.

Typical Dosing Ranges

  • Transplant prophylaxis: Initial dosing often starts at 3-5 mg/kg/day, divided twice daily, with adjustments based on trough blood concentrations.
  • Severe psoriasis: Clinicians frequently begin at 2.5-5 mg/kg/day, monitoring renal function and blood pressure.
  • Dry eye disease: One drop per eye twice daily is the standard regimen.

These examples illustrate common clinical practice; the exact dose must be individualized by a qualified healthcare professional.

Administration Guidelines

Oral cyclosporine should be taken consistently with respect to meals-most clinicians advise dosing on an empty stomach to reduce variability in absorption, though the microemulsion formulation may be taken with food. The ophthalmic emulsion must be instilled without touching the tip to the eye, and patients should wait at least 15 minutes before applying other eye drops.

A prescribing clinician should determine the precise regimen based on your medical history, concomitant medications, and laboratory monitoring.

Safety Profile & Considerations

Common Side Effects

  • Nephrotoxicity - Elevated serum creatinine in >10 % of patients; dose-dependent and reversible with adjustment.
  • Hypertension - New-onset or worsened blood pressure observed in roughly 12 % of transplant recipients.
  • Hyperlipidaemia - Increases in cholesterol and triglycerides reported in 8-15 % of users.
  • Gingival hyperplasia - Occurs in up to 15 % of long-term oral therapy patients.
  • Tremor - Mild to moderate tremor noted in 5-10 % of individuals.

Serious Adverse Events

  • Severe infection - Immunosuppression can predispose to opportunistic infections; immediate medical evaluation is required for fever or unexplained systemic symptoms.
  • Lymphoma and post-transplant malignancies - Rare but documented; vigilance for persistent lymphadenopathy or unexplained weight loss is essential.
  • Neurotoxicity - Seizures and posterior reversible encephalopathy syndrome (PRES) have been reported, albeit infrequently.

Contraindications

Cyclosporine should not be used in patients with uncontrolled hypertension, active severe infections, or known hypersensitivity to the drug or its excipients. It is also contraindicated in individuals with uncontrolled renal insufficiency (creatinine clearance <30 mL/min).

Drug Interactions

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) can raise cyclosporine levels, increasing toxicity risk.
  • CYP3A4 inducers (e.g., rifampin, phenytoin) may lower concentrations, reducing efficacy.
  • Other immunosuppressants (e.g., tacrolimus, mycophenolate) amplify infection risk.
  • Nephrotoxic agents (e.g., aminoglycosides, NSAIDs) heighten renal injury potential.

Patients should inform their clinician of all prescription drugs, over-the-counter products, and herbal supplements.

Special Populations

  • Pregnancy & Breastfeeding: Cyclosporine crosses the placenta and is excreted in breast milk; it is classified as pregnancy category C in Australia. Risks and benefits must be weighed carefully.
  • Elderly: Age-related renal decline may necessitate lower starting doses and more frequent monitoring.
  • Hepatic/Renal Impairment: Dose reductions are required for moderate to severe hepatic or renal dysfunction, with therapeutic drug monitoring guiding adjustments.

Frequently Asked Questions

  • How does cyclosporine differ from tacrolimus? Both are calcineurin inhibitors, but tacrolimus binds the FK-binding protein rather than cyclophilin. Tacrolimus generally has a higher potency per milligram and may cause fewer cosmetic side effects like gingival hyperplasia.

  • How long does cyclosporine take to work for psoriasis? Noticeable improvement typically appears after 6-8 weeks of consistent therapy, though maximal response may require 12 weeks or longer.

  • What foods should I avoid while taking cyclosporine? Grapefruit and pomelo can increase cyclosporine concentrations by inhibiting CYP3A4. Maintaining a stable diet and avoiding large fluctuations in fruit intake helps keep drug levels steady.

  • What should I do if I experience a tremor from cyclosporine? Minor tremor often resolves with dose adjustment. If the tremor is severe or interferes with daily activities, contact your clinician for possible reduction or substitution.

  • Can cyclosporine cause high blood pressure? Yes, hypertension is a common side effect affecting up to 12 % of patients. Regular blood pressure monitoring is advisable, and antihypertensive therapy may be required.

  • Is it safe to take cyclosporine with other immunosuppressants? Combination therapy can increase infection risk and should only be used under strict medical supervision with close laboratory monitoring.

  • Does taking cyclosporine with food affect its absorption? Oral cyclosporine’s bioavailability is reduced when taken with high-fat meals. Many clinicians advise dosing on an empty stomach, though the microemulsion formulation (Neoral) is less affected by food.

  • What is the importance of monitoring cyclosporine blood levels? Therapeutic drug monitoring ensures concentrations stay within a target range (typically 100-300 ng/mL for transplant patients). This balances efficacy against nephrotoxicity and other adverse effects.

  • How often should kidney function be checked while on cyclosporine? Baseline serum creatinine and eGFR should be measured before starting therapy, followed by monthly checks for the first three months and then every 3-6 months, or more frequently if renal function changes.

  • What information should I provide my doctor when discussing cyclosporine?

    • Complete list of current prescription, OTC, and herbal medications.
    • History of kidney disease, hypertension, or liver dysfunction.
    • Recent lab results, especially renal function and lipid profile.
    • Any prior episodes of infection or malignancy.

Disclaimer

The information provided about cyclosporine is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing cyclosporine for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing cyclosporine.

External Resources about Cyclosporine


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD